Cargando…
SUMO fusion technology for difficult-to-express proteins
The demands of structural and functional genomics for large quantities of soluble, properly folded proteins in heterologous hosts have been aided by advancements in the field of protein production and purification. Escherichia coli, the preferred host for recombinant protein expression, presents man...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129290/ https://www.ncbi.nlm.nih.gov/pubmed/16084395 http://dx.doi.org/10.1016/j.pep.2005.03.016 |
_version_ | 1783516752462741504 |
---|---|
author | Butt, Tauseef R. Edavettal, Suzanne C. Hall, John P. Mattern, Michael R. |
author_facet | Butt, Tauseef R. Edavettal, Suzanne C. Hall, John P. Mattern, Michael R. |
author_sort | Butt, Tauseef R. |
collection | PubMed |
description | The demands of structural and functional genomics for large quantities of soluble, properly folded proteins in heterologous hosts have been aided by advancements in the field of protein production and purification. Escherichia coli, the preferred host for recombinant protein expression, presents many challenges which must be surmounted in order to over-express heterologous proteins. These challenges include the proteolytic degradation of target proteins, protein misfolding, poor solubility, and the necessity for good purification methodologies. Gene fusion technologies have been able to improve heterologous expression by overcoming many of these challenges. The ability of gene fusions to improve expression, solubility, purification, and decrease proteolytic degradation will be discussed in this review. The main disadvantage, cleaving the protein fusion, will also be addressed. Focus will be given to the newly described SUMO fusion system and the improvements that this technology has advanced over traditional gene fusion systems. |
format | Online Article Text |
id | pubmed-7129290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71292902020-04-08 SUMO fusion technology for difficult-to-express proteins Butt, Tauseef R. Edavettal, Suzanne C. Hall, John P. Mattern, Michael R. Protein Expr Purif Article The demands of structural and functional genomics for large quantities of soluble, properly folded proteins in heterologous hosts have been aided by advancements in the field of protein production and purification. Escherichia coli, the preferred host for recombinant protein expression, presents many challenges which must be surmounted in order to over-express heterologous proteins. These challenges include the proteolytic degradation of target proteins, protein misfolding, poor solubility, and the necessity for good purification methodologies. Gene fusion technologies have been able to improve heterologous expression by overcoming many of these challenges. The ability of gene fusions to improve expression, solubility, purification, and decrease proteolytic degradation will be discussed in this review. The main disadvantage, cleaving the protein fusion, will also be addressed. Focus will be given to the newly described SUMO fusion system and the improvements that this technology has advanced over traditional gene fusion systems. Elsevier Inc. 2005-09 2005-04-09 /pmc/articles/PMC7129290/ /pubmed/16084395 http://dx.doi.org/10.1016/j.pep.2005.03.016 Text en Copyright © 2005 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Butt, Tauseef R. Edavettal, Suzanne C. Hall, John P. Mattern, Michael R. SUMO fusion technology for difficult-to-express proteins |
title | SUMO fusion technology for difficult-to-express proteins |
title_full | SUMO fusion technology for difficult-to-express proteins |
title_fullStr | SUMO fusion technology for difficult-to-express proteins |
title_full_unstemmed | SUMO fusion technology for difficult-to-express proteins |
title_short | SUMO fusion technology for difficult-to-express proteins |
title_sort | sumo fusion technology for difficult-to-express proteins |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129290/ https://www.ncbi.nlm.nih.gov/pubmed/16084395 http://dx.doi.org/10.1016/j.pep.2005.03.016 |
work_keys_str_mv | AT butttauseefr sumofusiontechnologyfordifficulttoexpressproteins AT edavettalsuzannec sumofusiontechnologyfordifficulttoexpressproteins AT halljohnp sumofusiontechnologyfordifficulttoexpressproteins AT matternmichaelr sumofusiontechnologyfordifficulttoexpressproteins |